Table 3. Diagnostic performance, by immunoblotting, of the test proteins screened against human sera clinically confirmed with an infection or other clinical presentation.
| Number of positive sera/total sera tested (% positivity rate) | ||||||
| CE | AE | NCC | Schist | Others | Healthy | |
| GST | 5/116 (4.3) | 2/89 (2.2) | 7/172 (4.1) | 1/78 (1.3) | 2/153 (1.3) | 1/70 (1.4) |
| HCF-AgB | 98/116 (84.5) | 7/9 (77.8) | 14/100 (14.0) | 5/50 (10.0) | 5/119 (4.2) | 3/70 (4.3) |
| EpC1-GST | 107/116 (92.2) | 4/89 (4.5) | 16/172 (9.3) | 1/78 (1.3) | 1/153 (0.65) | 3/70 (4.3) |
| EgTPx-GST | 39/100 (39.0) | 50/89 (56.2) | 14/72 (19.4) | 0/28 (0) | 5/29 (17.2) | 4/20 (20.0) |
| EgG5-GST | 14/23 (60.9) | 9/9 (100) | 32/72 (44.4) | 0/28 (0) | 5/29 (17.2) | 3/20 (15.0) |